Home ventilation for COPD patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of three different modalities of home non-invasive ventilation (NIV) compared to no home NIV in reducing hospital readmissions and mortality in COPD patients who experience acute hypercapnic respiratory failure. The trial aims to determine if a targeted ventilation strategy can improve patient outcomes and reduce healthcare costs through telemonitoring. Conducted across France, Spain, and Portugal, the study will enroll patients who have recently been treated for exacerbations of COPD and are persistently hypercapnic after NIV withdrawal.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 1\) Patients with COPD, GOLD C or D and Forced expiratory volume in one second (FEV1)\<65%;
* 2\) AHRF (pH\<7,35 and PaCO2≥45mm Hg (≥6kPa) treated more than 24h with Ventilation (non-invasive or invasive);
* 3\) 48h to 2 weeks with pH\>7.35, and PaCO2\>45 (\>6kPa) after NIV withdrawal, during daytime at rest without oxygen or ventilatory support (or with O2 if patients are not able to avoid O2 with immediate desaturation below 80%).

Exclusion Criteria:

1. Patient treated with chronic NIV or continuous positive airway pressure (CPAP) device, with ongoing treatment;
2. Primary diagnosis of restrictive lung disease causing hypercapnia i.e. obesity hypoventilation and chest wall disease, however these patients will be included if the "FEV1/Forced vital capacity (FVC)" ratio is \<60% and the FEV1 \<50% if the predominant defect is considered to be obstructive by the center clinician;
3. BMI \> 35 kg/m2;
4. Sedative medication causing hypercapnia (\> 3 drugs or more than 20mg of morphine/day);
5. Polygraphic diagnosis of Obstructive Sleep Apnoea Syndrome (AHI\>30/h (French criteria);
6. Cognitive impairment that would prevent informed consent into the trial
7. Pregnancy;
8. Tobacco use \< 10 pack-year;
9. Psychiatric disease necessitating anti-psychotic medication, ongoing treatment for drug or alcohol addiction, persons of no fixed abode post-discharge;
10. Unstable coronary artery syndrome;
11. Age \<18 years;
12. Inability to comply with the protocol;
13. Expected survival\<12 months due to any situation other than COPD disease;
14. Duration of ICU stay\>10 days;
15. No affiliated to national health insurance;
16. Measure of legal protection (guardianship, wardship or judicial protection) for patients over the age of majority.

Where it's running

• Groupe Hospitalier Pitié Salpêtrière-Charles Foix
  Paris, Île-de-France Region, France Recruiting

Study contacts

• Principal investigator: Jesus Gonzalez, MD — Hôpital Pitié Salpêtrière-Charles Foix, Paris, France ,
• Study coordinator: Angèle Guilbot
• Email: angele.guilbot@multihealthgroup.com
• Phone: +33-180-13-15-19

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Management of Chronic Obstructive Pulmonary Disease in Switzerland

  This study looks at how to better manage and treat people with COPD in Switzerland by checking their lung health and smoking history.

  Recruiting Cantonal Hospital, Baselland · Liestal, Basel-Landschaft · NCT02065921

• Flutter therapy added to chest physiotherapy after CABG in COPD patients

  This study tests whether adding Flutter therapy to standard chest physiotherapy helps post-CABG patients with mild-to-moderate COPD improve breathing more than chest physiotherapy alone.

  Recruiting Foundation University Islamabad · Rawalpindi · NCT07875049

• TPB-based cadence exercise and breathing training for COPD patients

  A TPB-based program tests whether breathing training, cadence-guided walking, or both can improve lung function, exercise capacity, and quality of life in adults with COPD.

  Recruiting Fu Jen Catholic University Hospital · New Taipei City, New Taipei City and 1 other locations · NCT07860008

• See how dynamic chest X-rays relate to COPD patterns and progression risk

  This study looks at existing dynamic chest radiography data to see if new imaging measurements can identify COPD patterns, gauge severity, and predict who may experience faster progression.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07762573

• Personalized mobile app warnings to reduce COPD flares

  A personalized mobile app tests whether providing temperature-related risk warnings and protective tips, in addition to usual COPD care, can lower COPD flare-ups over 12 months.

  Recruiting at 4 sites Centers for Disease Control and Prevention, China · Beijing and 3 other locations · NCT07656142

• CLEAR model to predict when people with severe COPD can be taken off ventilatory support

  This project will see if the CLEAR model can predict which adults with severe COPD on invasive or non‑invasive ventilation can be safely taken off ventilatory support.

  Recruiting Assiut University · Asyut, Assuit Egypt · NCT07579052

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.